➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Dow
Johnson and Johnson
Mallinckrodt
Harvard Business School

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

THALITONE Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

When do Thalitone patents expire, and what generic alternatives are available?

Thalitone is a drug marketed by Casper Pharma Llc and Monarch Pharms and is included in two NDAs.

The generic ingredient in THALITONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Thalitone

A generic version of THALITONE was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21st, 1986.

  Free Forever Trial

Summary for THALITONE
Drug patent expirations by year for THALITONE
Pharmacology for THALITONE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for THALITONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc THALITONE chlorthalidone TABLET;ORAL 019574-001 Dec 20, 1988 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Casper Pharma Llc THALITONE chlorthalidone TABLET;ORAL 019574-002 Feb 12, 1992 BX RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
Monarch Pharms THALITONE chlorthalidone TABLET;ORAL 088051-001 Nov 12, 1982 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Dow
Johnson and Johnson
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.